Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Yelena Yuriy Janjigian, Francisco Sanchez-Vega, Yaelle Tuvy, Nancy Bouvier, Jamie Cathleen Riches, Matthew Margolis, Brittanie M Millang, Sasinya N. Scott, Ritika Kundra, Pau Castel, Geoffrey Yuyat Ku, Jaclyn Frances Hechtman, David Paul Kelsen, David H. Ilson, Efsevia Vakiani, Maurizio Scaltriti, David B. Solit, Barry S. Taylor, Michael F. Berger, Nikolaus Schultz
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2889808297